Cargando…
Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis
BACKGROUND: In the last years, levothyroxine (LT4) has been commercialized also in liquid formulation, which is less sensitive to the factors known to reduce the absorption of tablet LT4. To date, there is no robust information that liquid LT4 can improve pharmacologic thyroid homeostasis of patient...
Autores principales: | Virili, Camilla, Giovanella, Luca, Fallahi, Poupak, Antonelli, Alessandro, Santaguida, Maria Giulia, Centanni, Marco, Trimboli, Pierpaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790785/ https://www.ncbi.nlm.nih.gov/pubmed/29434573 http://dx.doi.org/10.3389/fendo.2018.00010 |
Ejemplares similares
-
Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018) -
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021) -
Ulcerative Colitis as a Novel Cause of Increased Need for Levothyroxine
por: Virili, Camilla, et al.
Publicado: (2019) -
Levothyroxine Therapy in Gastric Malabsorptive Disorders
por: Virili, Camilla, et al.
Publicado: (2021) -
Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)